Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,016 public trials 548 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

NCT04329728

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UCLA Medical Center of Hematology/Oncology Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
View Trial Details
Recruiting

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

NCT04972942

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Phoenix Children's Hospital Phoeniz, Arizona, United States
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • University of California Los Angeles, California, United States
  • University of California San Francisco, California, United States
View all 16 locations
View Trial Details
Recruiting

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

NCT04560322

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

NCT05645107

Conditions
Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
Locations
  • GC2202 Study Site 115 Huntington Park, California, United States
  • GC2202 Study Site 103 St. Petersburg, Florida, United States
  • GC2202 Study Site 111 Bethesda, Maryland, United States
  • GC2202 Study Site 109 Greenville, North Carolina, United States
View all 62 locations
View Trial Details

Related conditions